Publications by Samy Y. Lamouille

Katsuno Y, Qin J, Oses-Prieto J, Wang H, Jackson-Weaver O, Zhang T, Lamouille S, Wu J, Burlingame A, Xu J, Derynck R. (2018). Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation. Journal of Biological Chemistry 293: 13059-72.

James CC, Zeitz MJ, Calhoun PJ, Lamouille S, Smyth JW. (2018). Altered translation initiation of Gja1 limits gap junction formation during epithelial-mesenchymal transition. Molecular Biology of the Cell 29(7): 773-880.

Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, Simonds GR, Gourdie RG, Sheng Z. (2016). Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research 76(1): 139-49.

Smyth JW, Zhang SS, Sanchez JM, Lamouille S, Vogan JM, Hesketh GG, Hong T, Tomaselli GF, Shaw RM. (2014). A 14-3-3 mode-1 binding motif initiates gap junction internalization during acute cardiac ischemia. Traffic 15(6): 684-699.

Lamouille S, Xu J, Derynck R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology 15: 178-96.

Lamouille S, Subramanyam D, Blelloch R, Derynck R. (2013). Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Current Opinion in Cell Biology 25(2).

Lamouille S, Subrmanyam D, Blelloch R, Deyrnck R. (2013). Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs. Current Opinion in Cell Biology 25(2): 200-07.

Katsuno Y, Lamouille S, Derynck R. (2013). TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Current Opinion in Oncology 25(1).

Lamouille S, Connolly E, Smyth JW, Akhurst RJ, Derynck R. (2012). TGF-β induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. Journal of Cell Science 1(125).

Lamouille S, Connonlly E, Smyth JW, Akhurst RJ, Derynck R. (2012). TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. Journal of Cell Science 125: 1259-73.

Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R, Blelloch R. (2011). Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells. Nature Biotechnology 29(5): 443-8.

Lamouille S, Derynck R. (2009). Oncogene and tumour suppressor: the two faces of SnoN. The EMBO Journal 28(22): 3459-60.

Liu C, Xu P, Lamouille S, Xu J, Derynck R. (2009). TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling. Molecular Cell 35(1): 26-36.

Xu J, Lamouille S, Derynck R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Research 19: 156-72.

David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S. (2007). Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. Journal of Cellular Physiology 213(2): 484-9.

Lamouille S, Mallet C, Feige JJ, Bailly S. (2002). Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100(13): 4495-501.